StockFetcher Forums · General Discussion · EARNINGS PLAYS<< 1 2 3 4 5 ... 10 >>Post Follow-up
karennma
6,828 posts
msg #82282
Ignore karennma
modified
11/2/2009 5:40:33 PM

traderpro
- traderpro 11/1/2009 7:58:00 PM
CRXL...earnings out on tuesday (BEFORE THE OPEN 11-03-09)...looks like something leaked...record volume ...option pain 22.50
===================================================================================

Geesh!
If those are call options BOUGHT, not sold ... CRXL will make a HUGE move!

HERE




machismo
115 posts
msg #82288
Ignore machismo
11/2/2009 7:04:50 PM

CAR up 7% after hours on earnings.

Kevin_in_GA
4,548 posts
msg #82305
Ignore Kevin_in_GA
11/3/2009 8:23:20 AM

Looks like it is calls SOLD???

Nov. 3, 2009, 2:27 a.m. EST

Crucell Q3 profit falls 22%, but outlook unchanged

AMSTERDAM (MarketWatch) -- Dutch biotechnology firm Crucell NV (CRXL.AE) Tuesday stuck to its full-year outlook despite posting a steeper-than-expected drop in third-quarter net profit, hurt by income tax charges and lower income from its vaccine licenses.

Crucell, which makes vaccines for influenza, children's diseases and hepatitis B, reported a third quarter net profit of EUR10 million, from EUR12.8 million a year earlier.

Four analysts polled by Dow Jones Newswires forecast net profit of EUR11.9 million. The bottom line figure was hurt by high income tax charges in Switzerland and South Korea, where Crucell has research & development and manufacturing facilities.

Still, operating profit jumped to EUR15.5 million, from EUR9.6 million a year earlier.

Total revenue and other operating income rose 15% to EUR94.3 million, mainly driven by strong sales of Quinvaxem, a vaccine for protection against five potentially deadly childhood diseases, including diphteria and tetanus.

The Leiden-based company reiterated its guidance for 2009, saying it expects combined full-year total revenue and other operating income to grow by 20% at constant currencies.

Crucell shares closed at EUR13.48 Monday. The stock has lost around 22% in the past three months, as takeover rumors subsided after the purchase of an 18% stake in Crucell in September by U.S. pharmaceuticals giant Johnson & Johnson (JNJ 60.10, +0.61, +1.03%) .

I'm guessing the Nov 22.5 calls are going to drop like a stone.

Why can't you tell the difference between buying volume and selling volume on options? That would have made things a whole lot clearer, don't you think?



karennma
6,828 posts
msg #82311
Ignore karennma
11/3/2009 8:50:29 AM

That's the problem with these graphs.
Call volume is HUGE, but to make profitable earnings trades, we need to know THE DAY BEFORE ... are these calls SOLD or bought ....
Thanks, Kevin.


karennma
6,828 posts
msg #82312
Ignore karennma
11/3/2009 8:55:42 AM

Kevin_in_GA
- Kevin_in_GA 11/3/2009 8:23:20 AM

Looks like it is calls SOLD???
Nov. 3, 2009, 2:27 a.m. EST
Crucell Q3 profit falls 22%, but outlook unchanged

I'm guessing the Nov 22.5 calls are going to drop like a stone.
Why can't you tell the difference between buying volume and selling volume on options? That would have made things a whole lot clearer, don't you think?
=========================================================================================

Indeed!
The volume data is totally USELESS if you don't know whether the calls were SOLD or bought.
Clearly they were SOLD.
Call SELLERS will keep the premium. Call buyers will be the losers.





karennma
6,828 posts
msg #82313
Ignore karennma
modified
11/3/2009 9:04:45 AM

Kevin:
While we're screwing around with earnings plays, the E-Z money is being made in TNA and FAS puts.
FAS DOWN 24% from it's highs.

Best cheap inverse ETF play is FXP, IMHO.


karennma
6,828 posts
msg #82317
Ignore karennma
modified
11/3/2009 9:38:56 AM

Kevin:
Look at FAZ since 10-14-09.
What does THAT tell ya' .. ?
Also, I believe in following GS.
Look at GS chart since 10-14-09.


Kevin_in_GA
4,548 posts
msg #82318
Ignore Kevin_in_GA
11/3/2009 9:40:06 AM

Keith??

karennma
6,828 posts
msg #82319
Ignore karennma
11/3/2009 9:41:45 AM

Okay .... I'll keep this thread for "earnings plays", and start another called ETFs.
:>)
(as per our beloved, departed "alf". let's stay "organized'!!)


karennma
6,828 posts
msg #82321
Ignore karennma
modified
11/3/2009 9:54:05 AM

Kevin_in_GA
- Kevin_in_GA 11/3/2009 9:40:06 AM

Keith??
======================================

Sorry, KEVIN.
I have Alzheimers.
LOL!

Now you know the REAL reason why I have to do "short-term" trades.
I've got CRS! (can't remember sh*+)



StockFetcher Forums · General Discussion · EARNINGS PLAYS<< 1 2 3 4 5 ... 10 >>Post Follow-up

*** Disclaimer *** StockFetcher.com does not endorse or suggest any of the securities which are returned in any of the searches or filters. They are provided purely for informational and research purposes. StockFetcher.com does not recommend particular securities. StockFetcher.com, Vestyl Software, L.L.C. and involved content providers shall not be liable for any errors or delays in the content, or for any actions taken based on the content.


Copyright 2016 - Vestyl Software L.L.C.Terms of Service | License | Questions or comments? Contact Us
EOD Data sources: DDFPlus & CSI Data Quotes delayed during active market hours. Delay times are at least 15 mins for NASDAQ, 20 mins for NYSE and Amex. Delayed intraday data provided by DDFPlus